Bicycle Therapeutics (BCYC) Non Operating Income (2018 - 2026)

Bicycle Therapeutics (BCYC) has 9 years of Non Operating Income data on file, last reported at $4.3 million in Q2 2026.

• Quarterly Non Operating Income fell 41.83% year-over-year to $4.3 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $21.6 million (down 46.09% YoY) and the FY2025 annual result came in at $28.3 million, down 21.67% from the prior year.
• Non Operating Income fell to $4.3 million in Q2 2026, from $4.8 million in the prior quarter.
• In the past five years, Non Operating Income ranged from a high of $14.7 million in Q4 2024 to a low of -$600000.0 in Q1 2022.
• A 5-year average of $4.8 million and a median of $4.8 million in 2024 frame the typical range for Non Operating Income.
• Annual changes were most pronounced in 2023 — Non Operating Income plunged 136.0% — and 2024, when it soared 77322.22%.
• Tracing BCYC's Non Operating Income over 5 years: stood at $1.8 million in 2022, then surged by 200.94% to $5.5 million in 2023, then jumped by 169.92% to $14.7 million in 2024, then plunged by 60.49% to $5.8 million in 2025, then fell by 25.83% to $4.3 million in 2026.
• The last three Non Operating Income figures came in at $4.3 million (Q2 2026), $4.8 million (Q1 2026), and $5.8 million (Q4 2025), per Business Quant data.